vs
Side-by-side financial comparison of Celcuity Inc. (CELC) and RadNet, Inc. (RDNT). Click either name above to swap in a different company.
Celcuity Inc. is a clinical-stage biotechnology company specializing in oncology. It develops personalized cancer treatment solutions through its proprietary functional cell analysis technology, targeting unmet medical needs for patients with hard-to-treat solid tumors, with primary operations in the U.S. and partnerships across global biopharmaceutical networks.
RadNet is an American radiology firm. The company operates outpatient diagnostic imaging services. Headquartered in Los Angeles, California, RadNet is the largest operator of freestanding, fixed-site diagnostic imaging centers in the United States, based on the number of locations and annual imaging revenue. As of 2025, the company owns and/or operates over 400 imaging centers across Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $547.7M | ||
| Q3 25 | — | $522.9M | ||
| Q2 25 | — | $498.2M | ||
| Q1 25 | — | $471.4M | ||
| Q4 24 | — | $477.1M | ||
| Q3 24 | — | $461.1M | ||
| Q2 24 | — | $459.7M | ||
| Q1 24 | — | $431.7M |
| Q4 25 | — | $-597.0K | ||
| Q3 25 | — | $5.4M | ||
| Q2 25 | — | $14.5M | ||
| Q1 25 | — | $-37.9M | ||
| Q4 24 | — | $5.3M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | — | $-3.0M | ||
| Q1 24 | — | $-2.8M |
| Q4 25 | — | 5.1% | ||
| Q3 25 | — | 5.2% | ||
| Q2 25 | — | 6.2% | ||
| Q1 25 | — | -5.1% | ||
| Q4 24 | — | 5.1% | ||
| Q3 24 | — | 7.4% | ||
| Q2 24 | — | 7.6% | ||
| Q1 24 | — | 2.6% |
| Q4 25 | — | -0.1% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | -8.0% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | -0.6% | ||
| Q1 24 | — | -0.6% |
| Q4 25 | — | $0.00 | ||
| Q3 25 | — | $0.07 | ||
| Q2 25 | — | $0.19 | ||
| Q1 25 | — | $-0.51 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | $-0.04 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
